ARCHIVES

Communication Is Key To Clinical Trial Enrollment

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

NCI Workshop Summary “Incomplete,” Kopans Writes In Letter

April 16, 1993

U-Miami Center Gets $27.5 Million Gift for Cancer Programs

October 31, 1986

St. Jude Begins $100 Million Expansion Program

December 4, 1987

National Organ Site Programs Successful, But Reappraisal Will Continue: Upton

June 23, 1978

Chemical Carcinogenesis

November 18, 1994